Terms: = Endocrine gland cancer AND CEBPA, CEBP, 1050, C/EBP-alpha, P49715
125 results:
1. Mapping the EORTC QLQ-C30 and QLQ H&N35 to the EQ-5D-5L and SF-6D for papillary thyroid carcinoma.
Huang D; Zeng D; Tang Y; Jiang L; Yang Q
Qual Life Res; 2024 Feb; 33(2):491-505. PubMed ID: 37938402
[TBL] [Abstract] [Full Text] [Related]
2. Apoptotic Effect of Gallic Acid via Regulation of p-p38 and ER Stress in PANC-1 and MIA PaCa-2 Cells Pancreatic cancer Cells.
Kim JW; Choi J; Park MN; Kim B
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894916
[TBL] [Abstract] [Full Text] [Related]
3. Obtaining SF-6D utilities from FACT-H&N in thyroid carcinoma patients: development and results from a mapping study.
Yang Q; Huang D; Jiang L; Tang Y; Zeng D
Front Endocrinol (Lausanne); 2023; 14():1160882. PubMed ID: 37664851
[TBL] [Abstract] [Full Text] [Related]
4. Overuse of thyroid ultrasound.
Acosta GJ; Singh Ospina N; Brito JP
Curr Opin Endocrinol Diabetes Obes; 2023 Oct; 30(5):225-230. PubMed ID: 37288725
[TBL] [Abstract] [Full Text] [Related]
5. Point-of-care testing: a disposable label-free electrochemical CA125 and HE4 immunosensors for early detection of ovarian cancer.
Bilgi Kamaç M; Altun M; Yılmaz M; Yılmaz Aktan A; Aktan S; Sezgintürk MK
Biomed Microdevices; 2023 May; 25(2):18. PubMed ID: 37140852
[TBL] [Abstract] [Full Text] [Related]
6. Silibinin, an HSP90 Inhibitor, on Human ACTH-Secreting Adenomas.
Pecori Giraldi F; Cassarino MF; Sesta A; Lasio G; Losa M
Neuroendocrinology; 2023; 113(6):606-614. PubMed ID: 36791678
[TBL] [Abstract] [Full Text] [Related]
7. Graphene Oxide Enhances Biogenesis and Release of Exosomes in Human Ovarian cancer Cells.
Gurunathan S; Kim JH
Int J Nanomedicine; 2022; 17():5697-5731. PubMed ID: 36466784
[TBL] [Abstract] [Full Text] [Related]
8. Diagnostic performance of simplified TI-RADS for malignant thyroid nodules: comparison with 2017 ACR-TI-RADS and 2020 C-TI-RADS.
Chen Z; Du Y; Cheng L; Zhang Y; Zheng S; Li R; Zhang W; Zhang W; He W
Cancer Imaging; 2022 Aug; 22(1):41. PubMed ID: 35978376
[TBL] [Abstract] [Full Text] [Related]
9. Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: a retrospective cohort study.
Zou S; Wang X; Chen H; Lin J; Wen C; Zhan Q; Chen H; Lu X; Deng X; Shen B
BMC Cancer; 2022 Jun; 22(1):649. PubMed ID: 35698045
[TBL] [Abstract] [Full Text] [Related]
10. Knockdown of ENTPD5 inhibits tumor metastasis and growth via regulating the GRP78/p-eIF-2α/CHOP pathway in serous ovarian cancer.
Chen X; Zha Z; Wang Y; Chen Y; Pang M; Huang L; Chen Y
J Ovarian Res; 2022 Jun; 15(1):69. PubMed ID: 35668504
[TBL] [Abstract] [Full Text] [Related]
11. [Expression and significance of GLI1 and Shh in the malignant transformation of ovarian endometriosis].
Zhao F; Yu XP; Zhao H; Song BB; Lyu AW; Zhang SH; Wang LM
Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):125-132. PubMed ID: 35184473
[No Abstract] [Full Text] [Related]
12. Endoscopic Cervical Lymph Node Dissection Using the Extra-cervical Anterior Chest Wall Approach: A New Technique.
Elzahaby IA; Shetiwy M; Hossam A; Elafy A
Surg Innov; 2022 Dec; 29(6):723-729. PubMed ID: 34823394
[TBL] [Abstract] [Full Text] [Related]
13. New Regions With Molecular Alterations in a Rare Case of Insulinomatosis: Case Report With Literature Review.
Anoshkin K; Vasilyev I; Karandasheva K; Shugay M; Kudryavtseva V; Egorov A; Gurevich L; Mironova A; Serikov A; Kutsev S; Strelnikov V
Front Endocrinol (Lausanne); 2021; 12():760154. PubMed ID: 34737724
[TBL] [Abstract] [Full Text] [Related]
14. Predictive Value of Serum Thyroglobulin for Structural Recurrence Following Lobectomy for Papillary Thyroid Carcinoma.
Xu S; Huang H; Zhang X; Huang Y; Guan B; Qian J; Wang X; Liu S; Xu Z; Liu J
Thyroid; 2021 Sep; 31(9):1391-1399. PubMed ID: 34340593
[No Abstract] [Full Text] [Related]
15. The Role of Cell Blocks and Immunohistochemistry in Thyroid Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Bethesda Category.
Abram M; Huhtamella R; Kalfert D; Hakso-Mäkinen H; Ludvíková M; Kholová I
Acta Cytol; 2021; 65(3):257-263. PubMed ID: 33789274
[TBL] [Abstract] [Full Text] [Related]
16. CCAAT enhancer binding protein α suppresses proliferation, metastasis, and epithelial-mesenchymal transition of ovarian cancer cells via suppressing the Wnt/β-catenin signaling.
Zhang LM; Li M; Tian CC; Wang TT; Mi SF
Neoplasma; 2021 May; 68(3):602-612. PubMed ID: 33780265
[TBL] [Abstract] [Full Text] [Related]
17. Salvage management of patients with relapsing testicular germ cell tumors.
Heidenreich A; Pfister D; Paffenholz P
Curr Opin Urol; 2021 May; 31(3):206-213. PubMed ID: 33742980
[TBL] [Abstract] [Full Text] [Related]
18. Diffusion-weighted imaging for predicting tumor consistency and extent of resection in patients with pituitary adenoma.
Ding W; Huang Z; Zhou G; Li L; Zhang M; Li Z
Neurosurg Rev; 2021 Oct; 44(5):2933-2941. PubMed ID: 33506362
[TBL] [Abstract] [Full Text] [Related]
19. Biomarkers and Strategies for Early Detection of Ovarian cancer.
Bast RC; Lu Z; Han CY; Lu KH; Anderson KS; Drescher CW; Skates SJ
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2504-2512. PubMed ID: 33051337
[TBL] [Abstract] [Full Text] [Related]
20. KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma.
Saglam O; Tang Z; Tang G; Medeiros LJ; Toruner GA
PLoS One; 2020; 15(9):e0238477. PubMed ID: 32877461
[TBL] [Abstract] [Full Text] [Related]
[Next]
